Concepts (219)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 59 | 2025 | 2176 | 7.770 |
Why?
|
| Thalamic Nuclei | 17 | 2025 | 24 | 6.130 |
Why?
|
| Image Enhancement | 28 | 2019 | 192 | 4.580 |
Why?
|
| Image Processing, Computer-Assisted | 25 | 2025 | 658 | 4.180 |
Why?
|
| Image Interpretation, Computer-Assisted | 23 | 2020 | 179 | 3.590 |
Why?
|
| Imaging, Three-Dimensional | 19 | 2019 | 284 | 3.450 |
Why?
|
| White Matter | 11 | 2025 | 123 | 3.360 |
Why?
|
| Brain Mapping | 7 | 2024 | 232 | 2.560 |
Why?
|
| Algorithms | 26 | 2020 | 1003 | 1.900 |
Why?
|
| Thalamus | 8 | 2024 | 73 | 1.660 |
Why?
|
| Signal Processing, Computer-Assisted | 8 | 2017 | 97 | 1.630 |
Why?
|
| Multiple Sclerosis | 9 | 2024 | 218 | 1.450 |
Why?
|
| Alcoholism | 8 | 2025 | 318 | 1.440 |
Why?
|
| Echo-Planar Imaging | 7 | 2016 | 33 | 1.400 |
Why?
|
| Brain | 9 | 2025 | 1552 | 1.200 |
Why?
|
| Neuroimaging | 3 | 2025 | 153 | 1.190 |
Why?
|
| Artifacts | 9 | 2018 | 125 | 1.180 |
Why?
|
| Gray Matter | 2 | 2025 | 35 | 1.050 |
Why?
|
| Alzheimer Disease | 5 | 2024 | 721 | 1.030 |
Why?
|
| Sensitivity and Specificity | 22 | 2017 | 1147 | 0.980 |
Why?
|
| Ventral Thalamic Nuclei | 3 | 2020 | 7 | 0.920 |
Why?
|
| Reproducibility of Results | 21 | 2025 | 1654 | 0.910 |
Why?
|
| Magnetic Resonance Angiography | 10 | 2011 | 186 | 0.900 |
Why?
|
| Cognitive Dysfunction | 4 | 2024 | 332 | 0.890 |
Why?
|
| Humans | 82 | 2025 | 63449 | 0.830 |
Why?
|
| Data Compression | 4 | 2018 | 9 | 0.790 |
Why?
|
| Essential Tremor | 5 | 2021 | 19 | 0.790 |
Why?
|
| Female | 54 | 2025 | 32883 | 0.770 |
Why?
|
| Adult | 39 | 2025 | 16826 | 0.750 |
Why?
|
| Schizophrenia | 1 | 2024 | 263 | 0.740 |
Why?
|
| Contrast Media | 12 | 2019 | 426 | 0.740 |
Why?
|
| Male | 49 | 2025 | 29893 | 0.730 |
Why?
|
| Kidney | 4 | 2019 | 446 | 0.660 |
Why?
|
| Glomerular Filtration Rate | 3 | 2019 | 112 | 0.660 |
Why?
|
| HIV Infections | 3 | 2024 | 969 | 0.650 |
Why?
|
| Middle Aged | 35 | 2025 | 17615 | 0.630 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2019 | 93 | 0.630 |
Why?
|
| Back Pain | 1 | 2019 | 51 | 0.620 |
Why?
|
| Aging | 5 | 2025 | 745 | 0.610 |
Why?
|
| Adipose Tissue | 4 | 2014 | 295 | 0.570 |
Why?
|
| Spine | 1 | 2018 | 49 | 0.570 |
Why?
|
| Aged | 26 | 2025 | 14449 | 0.550 |
Why?
|
| Breath Holding | 3 | 2015 | 7 | 0.540 |
Why?
|
| Physics | 1 | 2017 | 12 | 0.530 |
Why?
|
| Kidney Function Tests | 1 | 2017 | 37 | 0.530 |
Why?
|
| Breast Neoplasms | 6 | 2016 | 1198 | 0.500 |
Why?
|
| Abdomen | 3 | 2014 | 91 | 0.490 |
Why?
|
| Cerebellum | 3 | 2021 | 95 | 0.480 |
Why?
|
| Pattern Recognition, Automated | 3 | 2018 | 53 | 0.480 |
Why?
|
| Renal Artery | 2 | 2011 | 37 | 0.450 |
Why?
|
| Breast | 1 | 2016 | 183 | 0.440 |
Why?
|
| Neural Pathways | 4 | 2024 | 99 | 0.440 |
Why?
|
| Pulvinar | 2 | 2024 | 2 | 0.440 |
Why?
|
| Myocardial Infarction | 3 | 2013 | 916 | 0.420 |
Why?
|
| Young Adult | 10 | 2024 | 4695 | 0.410 |
Why?
|
| Red Nucleus | 2 | 2025 | 5 | 0.410 |
Why?
|
| Cardiac-Gated Imaging Techniques | 1 | 2013 | 8 | 0.410 |
Why?
|
| Hippocampus | 4 | 2024 | 270 | 0.400 |
Why?
|
| Deep Brain Stimulation | 3 | 2023 | 67 | 0.390 |
Why?
|
| Gadolinium | 2 | 2012 | 107 | 0.380 |
Why?
|
| Abdominal Neoplasms | 1 | 2012 | 22 | 0.370 |
Why?
|
| Renal Artery Obstruction | 1 | 2011 | 19 | 0.370 |
Why?
|
| Functional Laterality | 2 | 2024 | 138 | 0.370 |
Why?
|
| Atrophy | 6 | 2024 | 83 | 0.360 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2018 | 178 | 0.330 |
Why?
|
| Coronary Angiography | 4 | 2005 | 203 | 0.320 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2020 | 74 | 0.320 |
Why?
|
| Subtraction Technique | 4 | 2013 | 23 | 0.320 |
Why?
|
| Liver Neoplasms | 3 | 2018 | 297 | 0.310 |
Why?
|
| Liver Diseases | 2 | 2015 | 156 | 0.300 |
Why?
|
| Magnetic Resonance Imaging, Cine | 3 | 2007 | 108 | 0.300 |
Why?
|
| Phantoms, Imaging | 5 | 2019 | 214 | 0.290 |
Why?
|
| Kidney Diseases | 1 | 2009 | 176 | 0.270 |
Why?
|
| Aged, 80 and over | 10 | 2022 | 5463 | 0.270 |
Why?
|
| Signal-To-Noise Ratio | 2 | 2018 | 51 | 0.250 |
Why?
|
| Basal Ganglia | 1 | 2025 | 34 | 0.240 |
Why?
|
| Tremor | 1 | 2025 | 24 | 0.240 |
Why?
|
| Amygdala | 1 | 2025 | 83 | 0.230 |
Why?
|
| Postural Balance | 1 | 2025 | 65 | 0.230 |
Why?
|
| Heart Ventricles | 2 | 2005 | 261 | 0.220 |
Why?
|
| Gadolinium DTPA | 4 | 2013 | 87 | 0.220 |
Why?
|
| Organ Size | 1 | 2024 | 170 | 0.220 |
Why?
|
| Body Water | 2 | 2014 | 15 | 0.210 |
Why?
|
| Attention | 1 | 2024 | 147 | 0.200 |
Why?
|
| Case-Control Studies | 3 | 2021 | 1119 | 0.200 |
Why?
|
| Liver | 3 | 2016 | 855 | 0.190 |
Why?
|
| Epilepsy | 1 | 2023 | 111 | 0.190 |
Why?
|
| Memory, Episodic | 1 | 2021 | 20 | 0.180 |
Why?
|
| Respiratory Mechanics | 2 | 2011 | 56 | 0.180 |
Why?
|
| Reference Values | 3 | 2014 | 331 | 0.180 |
Why?
|
| Prodromal Symptoms | 1 | 2021 | 16 | 0.170 |
Why?
|
| Alcohol Abstinence | 1 | 2021 | 10 | 0.170 |
Why?
|
| Computer Simulation | 3 | 2015 | 477 | 0.170 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 1 | 2020 | 4 | 0.170 |
Why?
|
| Respiration | 6 | 2018 | 89 | 0.170 |
Why?
|
| High-Intensity Focused Ultrasound Ablation | 1 | 2020 | 5 | 0.170 |
Why?
|
| Coronary Vessels | 4 | 2003 | 119 | 0.170 |
Why?
|
| Heart | 1 | 2002 | 283 | 0.170 |
Why?
|
| Automation | 1 | 2020 | 54 | 0.170 |
Why?
|
| Cerebellar Nuclei | 1 | 2020 | 4 | 0.170 |
Why?
|
| Stereotaxic Techniques | 1 | 2020 | 29 | 0.170 |
Why?
|
| Reflex, Stretch | 1 | 2019 | 2 | 0.160 |
Why?
|
| Lymphography | 1 | 2020 | 11 | 0.160 |
Why?
|
| Urography | 2 | 2017 | 13 | 0.160 |
Why?
|
| Lymphatic Abnormalities | 1 | 2020 | 5 | 0.160 |
Why?
|
| Learning | 1 | 2021 | 182 | 0.160 |
Why?
|
| Motion | 2 | 2018 | 59 | 0.160 |
Why?
|
| CA2 Region, Hippocampal | 1 | 2019 | 1 | 0.150 |
Why?
|
| Aging, Premature | 1 | 2019 | 2 | 0.150 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2019 | 5 | 0.150 |
Why?
|
| Renal Insufficiency | 1 | 2019 | 65 | 0.150 |
Why?
|
| Prospective Studies | 3 | 2016 | 3293 | 0.150 |
Why?
|
| Child | 5 | 2020 | 4526 | 0.140 |
Why?
|
| Sex Factors | 1 | 2019 | 978 | 0.130 |
Why?
|
| Leiomyoma | 1 | 2016 | 18 | 0.130 |
Why?
|
| Uterine Neoplasms | 1 | 2016 | 34 | 0.130 |
Why?
|
| Poisson Distribution | 1 | 2016 | 53 | 0.120 |
Why?
|
| Retrospective Studies | 6 | 2020 | 6659 | 0.120 |
Why?
|
| Organometallic Compounds | 2 | 2014 | 65 | 0.120 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1996 | 294 | 0.110 |
Why?
|
| Meglumine | 1 | 2014 | 20 | 0.110 |
Why?
|
| Pancreas | 1 | 2015 | 151 | 0.110 |
Why?
|
| Lateral Thalamic Nuclei | 1 | 2014 | 1 | 0.110 |
Why?
|
| Knee Joint | 2 | 2019 | 298 | 0.110 |
Why?
|
| Magnetics | 1 | 2014 | 53 | 0.110 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2013 | 13 | 0.110 |
Why?
|
| Entorhinal Cortex | 1 | 2013 | 7 | 0.110 |
Why?
|
| Adolescent | 6 | 2015 | 6245 | 0.100 |
Why?
|
| Anatomic Landmarks | 1 | 2013 | 7 | 0.100 |
Why?
|
| Digestive System Diseases | 1 | 2013 | 14 | 0.100 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 1 | 2013 | 10 | 0.100 |
Why?
|
| Single-Blind Method | 1 | 2013 | 144 | 0.100 |
Why?
|
| Cross-Sectional Studies | 3 | 2025 | 2576 | 0.100 |
Why?
|
| Mammography | 2 | 2012 | 281 | 0.100 |
Why?
|
| Cerebral Cortex | 1 | 2014 | 262 | 0.100 |
Why?
|
| Neuropil | 1 | 2012 | 6 | 0.100 |
Why?
|
| Executive Function | 2 | 2024 | 65 | 0.100 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2013 | 153 | 0.100 |
Why?
|
| Arteries | 1 | 2013 | 81 | 0.090 |
Why?
|
| Memory Disorders | 1 | 2012 | 50 | 0.090 |
Why?
|
| Electrodes, Implanted | 2 | 2023 | 38 | 0.090 |
Why?
|
| Cognition Disorders | 1 | 2013 | 217 | 0.090 |
Why?
|
| Sample Size | 1 | 2012 | 65 | 0.090 |
Why?
|
| Memory | 2 | 2024 | 120 | 0.090 |
Why?
|
| Longitudinal Studies | 2 | 2025 | 1256 | 0.090 |
Why?
|
| Cartilage, Articular | 1 | 2011 | 78 | 0.090 |
Why?
|
| Bone and Bones | 1 | 2011 | 139 | 0.080 |
Why?
|
| Coronary Disease | 2 | 2002 | 246 | 0.080 |
Why?
|
| Evoked Potentials | 1 | 2010 | 39 | 0.080 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 215 | 0.070 |
Why?
|
| Fourier Analysis | 3 | 2016 | 32 | 0.070 |
Why?
|
| Feasibility Studies | 3 | 2007 | 568 | 0.070 |
Why?
|
| Neuropsychological Tests | 2 | 2024 | 392 | 0.070 |
Why?
|
| Time Factors | 3 | 2013 | 3768 | 0.070 |
Why?
|
| Muscle, Skeletal | 1 | 2011 | 741 | 0.060 |
Why?
|
| Head | 1 | 2007 | 55 | 0.060 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2007 | 165 | 0.060 |
Why?
|
| Observer Variation | 2 | 2018 | 214 | 0.060 |
Why?
|
| Coronary Circulation | 1 | 2005 | 52 | 0.060 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2005 | 13 | 0.060 |
Why?
|
| Stroke | 1 | 2014 | 1196 | 0.060 |
Why?
|
| Child, Preschool | 3 | 2015 | 1990 | 0.060 |
Why?
|
| Spin Labels | 2 | 2015 | 12 | 0.060 |
Why?
|
| Connectome | 1 | 2024 | 33 | 0.050 |
Why?
|
| Memory, Short-Term | 1 | 2024 | 60 | 0.050 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2004 | 9 | 0.050 |
Why?
|
| Diaphragm | 1 | 2004 | 22 | 0.050 |
Why?
|
| Ventricular Function | 1 | 2002 | 22 | 0.050 |
Why?
|
| Oxides | 1 | 2002 | 37 | 0.050 |
Why?
|
| Sampling Studies | 1 | 2002 | 70 | 0.050 |
Why?
|
| Myocardium | 1 | 2005 | 279 | 0.050 |
Why?
|
| Pilot Projects | 3 | 2013 | 1008 | 0.050 |
Why?
|
| Systole | 1 | 2002 | 108 | 0.050 |
Why?
|
| Diastole | 1 | 2002 | 91 | 0.050 |
Why?
|
| Seizures | 1 | 2023 | 143 | 0.050 |
Why?
|
| Iron | 1 | 2002 | 148 | 0.050 |
Why?
|
| Healthy Volunteers | 1 | 2021 | 74 | 0.040 |
Why?
|
| Comorbidity | 1 | 2024 | 1120 | 0.040 |
Why?
|
| Anesthesia, General | 1 | 2020 | 46 | 0.040 |
Why?
|
| Osteolysis, Essential | 1 | 2020 | 2 | 0.040 |
Why?
|
| Thoracic Duct | 1 | 2020 | 3 | 0.040 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2020 | 58 | 0.040 |
Why?
|
| Rare Diseases | 1 | 2020 | 42 | 0.040 |
Why?
|
| Lymphatic Vessels | 1 | 2020 | 32 | 0.040 |
Why?
|
| Atlases as Topic | 1 | 2019 | 9 | 0.040 |
Why?
|
| Carotid Arteries | 1 | 2019 | 61 | 0.040 |
Why?
|
| Chronic Disease | 2 | 2015 | 753 | 0.040 |
Why?
|
| Patient-Centered Care | 1 | 2000 | 254 | 0.030 |
Why?
|
| Equipment Design | 2 | 2012 | 352 | 0.030 |
Why?
|
| Cognition | 1 | 2021 | 484 | 0.030 |
Why?
|
| Pelvis | 1 | 2016 | 59 | 0.030 |
Why?
|
| Methane | 1 | 1996 | 4 | 0.030 |
Why?
|
| Models, Structural | 1 | 1996 | 25 | 0.030 |
Why?
|
| Hydrocarbons | 1 | 1996 | 9 | 0.030 |
Why?
|
| Lactates | 1 | 1996 | 29 | 0.030 |
Why?
|
| Software | 2 | 2013 | 389 | 0.030 |
Why?
|
| Hepatic Artery | 1 | 2015 | 20 | 0.030 |
Why?
|
| Multiphasic Screening | 1 | 2015 | 1 | 0.030 |
Why?
|
| Reference Standards | 1 | 2015 | 73 | 0.030 |
Why?
|
| Lactic Acid | 1 | 1996 | 76 | 0.030 |
Why?
|
| Angiography | 1 | 2015 | 153 | 0.030 |
Why?
|
| Liver Cirrhosis | 1 | 2015 | 173 | 0.030 |
Why?
|
| Lipids | 1 | 1996 | 315 | 0.030 |
Why?
|
| Focal Nodular Hyperplasia | 1 | 2013 | 4 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2012 | 75 | 0.020 |
Why?
|
| Mental Recall | 1 | 2012 | 93 | 0.020 |
Why?
|
| Water | 1 | 2013 | 309 | 0.020 |
Why?
|
| Infant | 1 | 2014 | 1645 | 0.020 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2005 | 24 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2005 | 156 | 0.010 |
Why?
|
| Thorax | 1 | 2004 | 34 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2005 | 139 | 0.010 |
Why?
|
| Fibrosis | 1 | 2005 | 160 | 0.010 |
Why?
|
| Ferrosoferric Oxide | 1 | 2002 | 18 | 0.010 |
Why?
|
| Dextrans | 1 | 2002 | 46 | 0.010 |
Why?
|
| Magnetite Nanoparticles | 1 | 2002 | 28 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2002 | 608 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2003 | 554 | 0.010 |
Why?
|
| Pentetic Acid | 1 | 1997 | 33 | 0.010 |
Why?
|